Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ypmed.2021.106595 http://scihub22266oqcxt.onion/10.1016/j.ypmed.2021.106595 34217414!8722181!34217414     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Prev+Med 2021 ; 151 (ä): 106595 Nephropedia Template TP {{tp|p=34217414|t=2021. Cancer screening in the U S through the COVID-19 pandemic, recovery, and beyond |pdf=|usr=}}{{34217414}} gab.com Text Cancer screening in the U S through the COVID-19 pandemic, recovery, and beyond JO: Prev Med http://www.kidney.de/pget.php?&tw=1&pmid=34217414 #FOAvip COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmatic considerations can help guide prioritization efforts. Targeting guideline-eligible people who have never been screened, or those who are significantly out of date with screening, has the potential to maximize benefits now and into the future. Disruptions to care due to the pandemic could represent an unparalleled opportunity to reassess early detection programs towards an explicit, thoughtful, and just prioritization of populations historically experiencing cancer disparities. By focusing screening services on populations that have the most to gain, and by careful and deliberate planning for the period following the pandemic, we can positively affect cancer outcomes for all. Twit Text FOAVip Cancer screening in the U S through the COVID-19 pandemic, recovery, and beyond ????Prev Med http://www.kidney.de/pget.php?&tw=1&pmid=34217414 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34217414 #FOAvip English Wikipedia <ref>{{Cite pmid|34217414}}</ref> Cancer screening in the U S through the COVID-19 pandemic, recovery, and beyond #MMPMID34217414 Croswell JM; Corley DA; Lafata JE; Haas JS; Inadomi JM; Kamineni A; Ritzwoller DP; Vachani A; Zheng Y Prev Med 2021[Oct]; 151 (ä): 106595 PMID34217414show ga COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmatic considerations can help guide prioritization efforts. Targeting guideline-eligible people who have never been screened, or those who are significantly out of date with screening, has the potential to maximize benefits now and into the future. Disruptions to care due to the pandemic could represent an unparalleled opportunity to reassess early detection programs towards an explicit, thoughtful, and just prioritization of populations historically experiencing cancer disparities. By focusing screening services on populations that have the most to gain, and by careful and deliberate planning for the period following the pandemic, we can positively affect cancer outcomes for all. |*COVID-19[MESH] |*Neoplasms/diagnosis/epidemiology[MESH] |Delivery of Health Care[MESH] |Early Detection of Cancer[MESH] |Humans[MESH] |Pandemics/prevention & control[MESH]Cancer screening in the U S through the COVID-19 pandemic, recovery, (epmc).pdf DeepDyve Pubget Overpricing